Synthesis of a 2,5-diaryloxazoline as a potential platelet-activating factor antagonist

DOI: 10.1002/jhet.5570310229

Source and publish data:

Journal of Heterocyclic Chemistry p. 419 - 423 (1994)

Update date:2022-08-05

Topics:

Authors:

Peet Peet

Burkhart

Broersma

Heminger

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jhet.5570310229

2,5-Bis-(3,4,5-trimethoxyphenyl)-2-oxazoline (5, MDL 100,270) was designed as a potential platelet-activating factor (PAF) antagonist on the basis of computer modeling comparison studies with known PAF antagonists. An efficient, four-step synthesis of oxa

Full text of DOI:10.1002/jhet.5570310229

Products guided by the article

Product name:N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide

Cas No:38165-13-8

R&D Labs maybe for 38165-13-8

Huangshi Meifeng Chemical Co.,ltd.

Contact:+86-714-6516706

Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

website:http://www.jlpharms.com

Contact:86-571-86982636

Address:Rm A606, Fuyi Center, jianqiao street
Fujian Wanke Pharmaceutical Co., LTD.

Contact:+86-598-5026002

Address:Economic development zone,jiangle county
JiYi Chemical (Beijing) Co., Ltd.

Contact:+86-10-89385733

Address:Shilou Town of Fangshan District， Beijing
Shuanghe Bio-Technology Limited(expird)

Contact:+86-571-61710758,18968016640

Address:Jinqiao north road 916# Fuyang

Relevant to this article

An unprecedented oxidative intermolecular homo coupling reaction between two sp³C–sp³C centers under metal-free condition

Doi:10.1016/j.tetlet.2016.06.092
(2016)
Direct synthesis of the isosteric phosphono analogues of α-L-rhamnose 1-phosphate and β-L-fucose 1-phosphate

Doi:10.1080/07328309808001879
(1998)
Chiral palladium complex-catalyzed synthesis of optically active vinylchroman

Doi:10.1248/cpb.45.1209
(1997)
Doi:10.1021/jf60141a025
(1965)
Reactions of Carbonyl Compounds with Grignard Reagents in the Presence of Cerium Chloride

Doi:10.1021/ja00194a037
(1989)
Synthetic approaches to benzofuran containing Insulin Sensitivity Enhancer compounds for treatment of type II diabetes

Doi:10.3987/com-97-7820
(1997)

Article Doi